However, we found a striking decrease in the frequency of the most primitive LT-CML stem cells in recipients transplanted with CML-KLS+ cells expressing Smad3–S208A (Fig. 3i,j). This evidence concerns the gene SMAD3 and chronic myelogenous leukemia, BCR-ABL1 positive.